Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial

Published:2018-04 Issue:3 Volume:34 Page:250-255
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Baiza-Durán Leopoldo¹,Olvera-Montaño Oscar¹,Mercado-Sesma Arieh R.¹²,Oregon-Miranda Aldo A.¹,Lizárraga-Corona Alfredo,Ochoa-Tabares Juan C.,Pérez-Balbuena Ana L.,Montoya-Sánchez Irene M.,Saucedo-Rodríguez Laura R.,Mora-González Fernando,Gómez-Bastar Pedro A.,Villanueva-Najera Miguel A.,Sandoval-Delgadillo Laura I.,González-Lomelí M.,Páez-Garza Juan H.,Orozco-Carroll Mónica,Casillas-Magallanes Mauricio,

Affiliation:

1. Clinical Research Department, Laboratorios Sophia, SA de CV, Zapopan, México.

2. Department of Health-Disease Sciences, University Center of Tonala, University of Guadalajara, Guadalajara, Mexico.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2017.0056

Reference30 articles.

1. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States

2. How do GPs diagnose and manage acute infective conjunctivitis? A GP survey

3. Bacterial conjunctivitis

4. Conjunctivitis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and antibacterial activity evaluation of N (7) position-modified balofloxacins;Frontiers in Chemistry;2022-08-19

2. Moxifloxacin induces random migration in human corneal fibroblasts via the protein kinase C epsilon/zonula occludens-1 signaling pathway;European Journal of Pharmacology;2021-11

3. Efficacy of a Novel Ophthalmic Antimicrobial Drug Combination Toward a Large Panel of Staphylococcus aureus Clinical Ocular Isolates From Around the World;Cornea;2020-07-03

4. Correction to: Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial, by Baiza-Durán, L., Olvera-Montaño, O., Mercado-Sesma, A.R., and Oregon-Miranda, A.A. J Ocul Pharmacol Ther 2018;34(3):250-255. DOI: 10.1089/jop.2017.0056;Journal of Ocular Pharmacology and Therapeutics;2019-02